SCHEMBL3511652

SCHEMBL3511652

[CH2]S(=O)(=O)c1ccc(OC)nc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
KCNH2 Q12809 2/20 0.44
NNMT P40261 1/20 0.44
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
USP2 O75604 2/20 0.43
PABPC1 P11940 2/20 0.43
ALDH1A1 P00352 2/20 0.42
CA12 O43570 1/20 0.41
CA9 Q16790 1/20 0.41
NAMPT P43490 1/20 0.40
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
KDM4E B2RXH2 1/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 2/20 0.39
ALOX15 P16050 2/20 0.39
HTT P42858 2/20 0.39
PTGS1 P23219 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1688213 0.82 KCNH2 (0.56) CA1CA2KCNH2NNMTMEN1
SCHEMBL30269658 0.81 CA1 (0.47) CA1CA2KCNH2NNMTMEN1
SCHEMBL2120289 0.81 KDM4E (0.53) CA1CA2KCNH2NNMTMEN1
SCHEMBL28819367 0.81 CA1 (0.61) CA1CA2KCNH2NNMTMEN1
SCHEMBL119737 0.81 CA1 (0.47) CA1CA2KCNH2NNMTMEN1
SCHEMBL28016001 0.81 CA1 (0.47) CA1CA2KCNH2NNMTMEN1
SCHEMBL1422284 0.81 CA1 (0.61) CA1CA2KCNH2NNMTMEN1
SCHEMBL24010110 0.79 KCNH2 (0.47) CA1CA2KCNH2NNMTMEN1
Hydrochloric Acid SCHEMBL29969325 0.79 CA1 (0.60) CA1CA2KCNH2NNMTMEN1
Hydrochloric Acid SCHEMBL28016002 0.79 KDM4E (0.52) CA1CA2KCNH2NNMTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8293919-B2 Antibacterial sulfone and sulfoxide substituted heterocyclic urea compounds CRESTONE, INC. (US) 2012-10-23 US claimed
US-20100286169-A1 Antibacterial Sulfone and Sulfoxide Substituted Heterocyclic Urea Compounds CRESTONE, INC. (US) 2010-11-11 US claimed
WO-2009015193-A1 ANTIBACTERIAL SULFONE AND SULFOXIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS REPLIDYNE, INC. (US) 2009-01-29 WO claimed
CN-111393414-A 4-methylsulfonyl substituted piperidine urea compounds for the treatment of Dilated Cardiomyopathy (DCM) 迈奥卡迪亚公司 2020-07-10 CN disclosed
CN-107428719-B 4-methylsulfonyl substituted piperidine urea compounds for the treatment of Dilated Cardiomyopathy (DCM) 迈奥卡迪亚公司 2020-03-27 CN disclosed
US-8293919-B2 Antibacterial sulfone and sulfoxide substituted heterocyclic urea compounds CRESTONE, INC. (US) 2012-10-23 US disclosed
US-20100286169-A1 Antibacterial Sulfone and Sulfoxide Substituted Heterocyclic Urea Compounds CRESTONE, INC. (US) 2010-11-11 US disclosed
WO-2009015193-A1 ANTIBACTERIAL SULFONE AND SULFOXIDE SUBSTITUTED HETEROCYCLIC UREA COMPOUNDS REPLIDYNE, INC. (US) 2009-01-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286169-A1 Antibacterial Sulfone and Sulfoxide Substituted Heterocyclic Urea Compounds TST, UMPS, UROD CA1 4273/4885CA2 4417/4885KCNH2 3087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.